Menu
Fechar
hrs4r
 I want to donate
Firma
ARANTXA ERASO-URIÉN
Position
Cap de Grup - R4
Group leader - R4
Projectes
Publicacions

Projectes

Cardiovascular Genetics

Impacto de un programa estructurado de ejercicio físico y control de factores de riesgo cardiovasculares en prevención primaria de cardiotoxicidad en pacientes con cáncer de mama sometidos a tratamientos cardiotóxicos: Estudio PREV

Codi oficial: Estudio PREV Start date:01/11/2021 Data fi: 31/12/2025 Investigador/a principal: ARANTXA ERASO URIÉN, SERGI MORAL TORRES Organisme finançador: FUNDACION MERCK SALUD
Radiation Oncology and Medical Physics of Girona

Linfadenectomía axilar versus radioterapia axilar en pacientes con ganglio centinela positivo tras terapia neodyuvante. Estudio multicéntrico randomizado fase III.

Codi oficial: ADARNAT I Start date:09/12/2022 Data fi: 09/12/2027 Investigador/a principal: LUIS MIGUEL ALONSO RUANO, ARANTXA ERASO URIÉN Organisme finançador: ASSOCIACIÓ ESPANYOLA CONTRA EL CÀNCER
Radiation Oncology and Medical Physics of Girona

Ajuts per donar suport a les activitats dels grups de recerca de Catalunya (SGR-Cat 2021) - Oncologia radioteràpica i Física Mèdica de Girona (ONCORFIM Girona)

Codi oficial: 2021 SGR 01463 - ONCORFIM Girona Start date:01/01/2022 Data fi: 30/06/2025 Investigador/a principal: ARANTXA ERASO URIÉN Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA
Radiation Oncology and Medical Physics of Girona

Preparatory activities to support Implementation of quality and Safety of Medical ionising radiation Applications

Codi oficial: 101162826 Start date:01/05/2024 Data fi: 31/10/2025 Investigador/a principal: ARANTXA ERASO URIÉN Organisme finançador: EUROPEAN COMISSION

Publicacions

Marruecos Querol J, Jurado-Bruggeman D, Lopez-Vidal A, Mesía Nin R, Rubió-Casadevall J, Buxó M, Eraso Urien A

Contouring aid tools in radiotherapy. Smoothing: the false friend

CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26, 1956-1967 dx.doi.org/10.1007/s12094-024-03420-9
Corral J, Algara M, Muñoz-Montplet C, Eraso A, Giralt J, Defourny N, Lievens Y, Borras JM

Challenges in assessing national radiotherapy costs: application of the ESTRO-HERO model in Spain.

Frontiers in Public Health, 2024, 12, 1474376-1474376 dx.doi.org/10.3389/fpubh.2024.1474376
Romera-Mart nez, I, Oliveras, I, Bux , M, Mart nez, J, Raspall, RF, Urien, AE, Nadal, EP, Vilanova, JC

DOSIMETRIC COMPARISON OF HEART SUBSTRUCTURES FOR DIBH BETWEEN FREE BREATHING FOR BREAST CANCER

RADIOTHERAPY AND ONCOLOGY, 2024, 194, 640-641
Sanz, CA, Romera-Mart nez, I, Jurado-Bruggeman, D, Urien, AE, Raspall, RF

Radiotherapy for gastric lymphoma. A proposal for improving treatment delivery and reproducibility

RADIOTHERAPY AND ONCOLOGY, 2024, 194, 1168-1170
Mu oz-Montplet, C, Jurado-Bruggeman, D, Eraso, A, Fuentes-Raspall, R

The Impact of Advanced Algorithms on the Treatment of Meningiomas

RADIOTHERAPY AND ONCOLOGY, 2024, 194, 3452-3454
Bonet, M, Recalde, E, Soto, A, Martinez, A, Murcia, M, Mases, J, Fernandez, MN, Yufera, JC, Alvarez, A, Eraso, MA, Feltes, N, Hernandez, L, Bernard, P, Ramos, L, Garcia, V

Use of social media in radiation oncology: multicenter data from the GOCO Group

Reports of Practical Oncology and Radiotherapy, 2024, 29, 236-244 dx.doi.org/10.5603/rpor.100386
Sais, E, PLUJA CASTELLANO, ANNA, MONTAÑES FERRER, CLAUDIA, Bujons-Buscarons, E, PINEDA RIVERO, FRANCISCO JAVIER, Iguaran A, Roselló À, Hernández Martínez A, Teixidor-Vilà, E, ROMERA, ALVARO, Bosch-Barrera, J, ERASO URIÉN, ARANTXA, Oliva-Poch E

1062P Effect of the immunological circadian rhythm on the treatment of locally advanced non-small cell lung cancer treated with consolidation immunotherapy

ANNALS OF ONCOLOGY, 2024, 35, 1-1 dx.doi.org/10.1016/j.annonc.2024.08.1120
Marruecos-Querol J, Rubió-Casadevall J, Lozano A, Buxó M, Puigdemont M, Linares I, Planas I, Vayreda J, Cirauqui B, Taberna M, Quiroga V, Tobed M, Borés A, Recalde S, Saigi M, Felip E, Eraso A, Mesía R

Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25, 2384-2392 dx.doi.org/10.1007/s12094-023-03121-9
Auñón C, Sanvisens A, Turon E, Vidal-Vila A, Puigdemont M, Osca-Gelis G, Eraso A, Marcos-Gragera R

Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018)

CANCER MEDICINE, 2023, 12, 12343-12353 dx.doi.org/10.1002/cam4.5935
Pardo García R, Piñero Madrona A, Algara López M, Bernet Vegué L, Eraso Urien A

Just medical oncology guidelines...

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25, 3319-3320 dx.doi.org/10.1007/s12094-023-03272-9

Formulari de contacte

About IDIBGI!

 menu